These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week. Bork K, Hardt J. Int Arch Allergy Immunol; 2011 Dec; 154(1):81-8. PubMed ID: 20664282 [Abstract] [Full Text] [Related]
12. Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report. Hermans C. Arch Gynecol Obstet; 2007 Sep; 276(3):271-6. PubMed ID: 17653743 [Abstract] [Full Text] [Related]
16. Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety. Hofstra JJ, Kleine Budde I, van Twuyver E, Choi G, Levi M, Leebeek FW, de Monchy JG, Ypma PF, Keizer RJ, Huitema AD, Strengers PF. Clin Immunol; 2012 Mar; 142(3):280-90. PubMed ID: 22197071 [Abstract] [Full Text] [Related]
17. Parameters of the classical complement pathway predict disease severity in hereditary angioedema. Csuka D, Füst G, Farkas H, Varga L. Clin Immunol; 2011 Apr; 139(1):85-93. PubMed ID: 21300570 [Abstract] [Full Text] [Related]
18. Summary of the International Multicenter Prospective Angioedema C1-inhibitor Trials 1 and 2 (IMPACT1 and 2). Krassilnikova S, Craig ET, Craig TJ. Expert Rev Clin Immunol; 2010 May; 6(3):327-34. PubMed ID: 20441418 [Abstract] [Full Text] [Related]